Pharmaron Beijing (HKG:3759, SHE:300759) reported a net profit attributable to owners of 308.4 million yuan for the quarter ended Sept. 30, a 12.62% drop from the previous year's quarter, according to a Tuesday filing with the Hong Kong bourse.
Earnings per share were 0.1744 yuan, a decline of 12.93% from a year earlier.
Revenue for the quarter increased 10.02% on-year to 3.21 billion yuan, according to the filing.
Price (HKD): $15.82, Change: $-0.60, Percent Change: -3.65%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments